FDA approves Ventana Medical's Her2/neu diagnostic

The FDA granted marketing approval for VMSI's Pathway (CB11) monoclonal antibody against Her2 to detect the c-erbB-2 (Her2) antigen in breast cancer tissue samples. The product is intended to identify...